{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:38:47Z","timestamp":1648615127801},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1001\/jamaoncol.2018.6716","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T21:32:08Z","timestamp":1549575128000},"page":"900","source":"Crossref","is-referenced-by-count":1,"title":["Pruritic Rash in a Woman With Hodgkin Lymphoma"],"prefix":"10.1001","volume":"5","author":[{"given":"Clayton","family":"Jackson","sequence":"first","affiliation":[{"name":"Wake Forest Baptist Medical Center, Department of Internal Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Strowd","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Medical Center, Comprehensive Cancer Center, Department of Dermatology, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zanetta","family":"Lamar","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Medical Center, Section of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"ccg180012r1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/bjd.2006.155.issue-5","article-title":"Bleomycin and the skin.","volume":"155","author":"Yamamoto","year":"2006","journal-title":"Br J Dermatol"},{"issue":"5","key":"ccg180012r2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/bjd.1994.131.issue-5","article-title":"Bleomycin-induced flagellate dermatitis: a clinical and histopathological review.","volume":"131","author":"Mowad","year":"1994","journal-title":"Br J Dermatol"},{"key":"ccg180012r3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijd.2007.46.issue-s3","article-title":"Bleomycin-induced flagellate dermatitis.","volume":"46","author":"Vuerstaek","year":"2007","journal-title":"Int J Dermatol"},{"issue":"1","key":"ccg180012r4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2165\/11537080-000000000-00000","article-title":"Flagellate dermatitis as a bleomycin-specific adverse effect of cytostatic therapy: a clinical-histopathologic correlation.","volume":"12","author":"Ziemer","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"25","key":"ccg180012r5","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma.","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"ccg180012r6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJMoa1708984","article-title":"Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin\u2019s lymphoma.","volume":"378","author":"Connors","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"ccg180012r7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jaad.2005.11.1055","article-title":"Cutaneous Hodgkin\u2019s disease.","volume":"58","author":"Introcaso","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"ccg180012r8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/archderm.1982.01650230046026","article-title":"Cutaneous Hodgkin\u2019s disease.","volume":"118","author":"Silverman","year":"1982","journal-title":"Arch Dermatol"},{"issue":"3","key":"ccg180012r9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.clindermatol.2016.02.011","article-title":"Polymorphic eruption of pregnancy.","volume":"34","author":"Taylor","year":"2016","journal-title":"Clin Dermatol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/5\/6\/900\/17666952\/jamaoncology_jackson_2019_cg_180012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T15:07:52Z","timestamp":1560438472000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.6716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.6716","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}